From Alpha to Omicron SARS-CoV-2 Variants: What Their Evolutionary Signatures Can Tell Us?

Overview

Journal J Med Virol

Specialty Microbiology

Date 2022 Jan 3

PMID 34978091

Citations 9

Authors

Robert Andreata-Santos

Luiz M R Janini

Ricardo Duraes-Carvalho

Affiliations

Soon will be listed here.

Citing Articles

The importance of equally accessible genomic surveillance in the age of pandemics.

Zeghbib S, Kemenesi G, Jakab F Biol Futur. 2023; 74(1-2):81-89.

PMID: 37199870 PMC: 10193332. DOI: 10.1007/s42977-023-00164-5.

Omicron SARS-CoV-2 Variants in an Genomic Comparison Study with the Original Wuhan Strain and WHO-Recognized Variants of Concern.

Elssaig E, Alnour T, Ullah M, Ahmed-Abakur E Pol J Microbiol. 2022; 71(4):577-587.

PMID: 36537060 PMC: 9944972. DOI: 10.33073/pjm-2022-053.

Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.

Dhama K, Nainu F, Frediansyah A, Yatoo M, Mohapatra R, Chakraborty S J Infect Public Health. 2022; 16(1):4-14.

PMID: 36446204 PMC: 9675435. DOI: 10.1016/j.jiph.2022.11.024.

AI-based search for convergently expanding, advantageous mutations in SARS-CoV-2 by focusing on oligonucleotide frequencies.

Ikemura T, Iwasaki Y, Wada K, Wada Y, Abe T PLoS One. 2022; 17(8):e0273860.

PMID: 36044525 PMC: 9432735. DOI: 10.1371/journal.pone.0273860.

Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?.

Dhawan M, Saied A, Mitra S, Alhumaydhi F, Emran T, Wilairatana P Biomed Pharmacother. 2022; 154:113522.

PMID: 36030585 PMC: 9376347. DOI: 10.1016/j.biopha.2022.113522.

References

Long S, Olsen R, Christensen P, Bernard D, Davis J, Shukla M . Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. mBio. 2020; 11(6). PMC: 7642679. DOI: 10.1128/mBio.02707-20. View

Nunes D, Torres Braconi C, Ludwig-Begall L, Arns C, Duraes-Carvalho R . Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution. PLoS One. 2022; 17(5):e0268389. PMC: 9129020. DOI: 10.1371/journal.pone.0268389. View

Chen J, Gao K, Wang R, Wei G . Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies. Chem Sci. 2021; 12(20):6929-6948. PMC: 8153213. DOI: 10.1039/d1sc01203g. View

Johnson B, Xie X, Bailey A, Kalveram B, Lokugamage K, Muruato A . Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021; 591(7849):293-299. PMC: 8175039. DOI: 10.1038/s41586-021-03237-4. View

Cerutti G, Guo Y, Zhou T, Gorman J, Lee M, Rapp M . Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe. 2021; 29(5):819-833.e7. PMC: 7953435. DOI: 10.1016/j.chom.2021.03.005. View

Lopez Bernal J, Gower C, Andrews N . Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply. N Engl J Med. 2021; 385(25):e92. DOI: 10.1056/NEJMc2113090. View

Abdelrahman Z, Li M, Wang X . Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front Immunol. 2020; 11:552909. PMC: 7516028. DOI: 10.3389/fimmu.2020.552909. View

Smaoui M, Yahyaoui H . Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain. Sci Rep. 2021; 11(1):9166. PMC: 8080587. DOI: 10.1038/s41598-021-88696-5. View

Gan H, Twaddle A, Marchand B, Gunsalus K . Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility. J Mol Biol. 2021; 433(15):167051. PMC: 8118711. DOI: 10.1016/j.jmb.2021.167051. View

10.

Yu F, Xiang R, Deng X, Wang L, Yu Z, Tian S . Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2. Signal Transduct Target Ther. 2020; 5(1):212. PMC: 7506210. DOI: 10.1038/s41392-020-00318-0. View

11.

Li X, Huang Y, Wang W, Jing Q, Zhang C, Qin P . Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study. Emerg Microbes Infect. 2021; 10(1):1751-1759. PMC: 8425710. DOI: 10.1080/22221751.2021.1969291. View

12.

Teng S, Sobitan A, Rhoades R, Liu D, Tang Q . Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity. Brief Bioinform. 2020; 22(2):1239-1253. PMC: 7665319. DOI: 10.1093/bib/bbaa233. View

13.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

14.

OConnell S, Anderson E, Jackson L, Luke C, Nason M, Roederer M . Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021; 373(6561):1372-1377. PMC: 8691522. DOI: 10.1126/science.abj4176. View

15.

van Dorp L, Acman M, Richard D, Shaw L, Ford C, Ormond L . Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020; 83:104351. PMC: 7199730. DOI: 10.1016/j.meegid.2020.104351. View

16.

Zahradnik J, Marciano S, Shemesh M, Zoler E, Harari D, Chiaravalli J . SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021; 6(9):1188-1198. DOI: 10.1038/s41564-021-00954-4. View

17.

Okonechnikov K, Golosova O, Fursov M . Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics. 2012; 28(8):1166-7. DOI: 10.1093/bioinformatics/bts091. View

18.

Verma J, Subbarao N . Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability. Virology. 2021; 561:107-116. PMC: 8237243. DOI: 10.1016/j.virol.2021.06.009. View

19.

Laurini E, Marson D, Aulic S, Fermeglia A, Pricl S . Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies. Sci Rep. 2021; 11(1):20274. PMC: 8511038. DOI: 10.1038/s41598-021-99827-3. View

20.

Barton M, MacGowan S, Kutuzov M, Dushek O, Barton G, Anton van der Merwe P . Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife. 2021; 10. PMC: 8480977. DOI: 10.7554/eLife.70658. View